Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiarou Wang

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of Translational Medicine|September 5, 2022
Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery diseaseXiaoteng Feng, Yifan Zhang, Min Du, et al.
Frontiers in Pharmacology|April 10, 2023
Catechins: Protective mechanism of antioxidant stress in atherosclerosisYuhan Sheng, Yizhuo Sun, Yang Tang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 4, 2023
Hydroxysafflor yellow A regulates lymphangiogenesis and inflammation via the inhibition of PI3K on regulating AKT/mTOR and NF-κB pathway in macrophages to reduce atherosclerosis in ApoE-/- miceXiaoteng Feng, Min Du, Sijin Li, et al.
Theranostics|October 3, 2022
Safety and efficacy of peptide receptor radionuclide therapy with <sup>177</sup>Lu-DOTA-EB-TATE in patients with metastatic neuroendocrine tumorsYuanyuan Jiang, Qingxing Liu, Guochang Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 26, 2024
Synthesis, preclinical evaluation and pilot clinical translation of [<sup>68</sup>Ga]Ga-PMD22, a novel nanobody PET probe targeting CLDN18.2 of gastrointestinal cancerRongxi Wang, Zhidong Bai, Wentao Zhong, et al.
Theranostics|April 17, 2026
Phase I dose-escalation study of [¹⁷⁷Lu]Lu-LNC1011, a long-circulating dansyl-modified PSMA theranostics, in metastatic castration-resistant prostate cancerJiarou Wang, Rongxi Wang, Jialin Xiang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2025
Comparison of [<sup>68</sup>Ga]Ga-Fibroblast Activation Protein Inhibitor-04 and [<sup>18</sup>F]FDG PET Imaging for Solitary Fibrous Tumor and Preliminary Application of FAP-Targeted Radiopharmaceutical TherapyRongxi Wang, Jiarou Wang, Jialin Xiang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 26, 2023
A prospective head-to-head comparison of [<sup>68</sup>Ga]Ga-P16-093 and [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancerGuochang Wang, Linlin Li, Ming Zhu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 4, 2023
Head-to-head comparison of [<sup>68</sup>Ga]Ga-P16-093 and 2-[<sup>18</sup>F]FDG PET/CT in patients with clear cell renal cell carcinoma: a pilot studyGuochang Wang, Linlin Li, Jiarou Wang, et al.
Clinical Nuclear Medicine|November 28, 2023
68 Ga-FAPI-04 PET/CT in Assessment of Fibroblast Activation in Keloids : A Prospective Pilot StudyJiarou Wang, Nanze Yu, Guochang Wang, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Translational Medicine|September 5, 2022
Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery diseaseXiaoteng Feng, Yifan Zhang, Min Du, et al.
Frontiers in Pharmacology|April 10, 2023
Catechins: Protective mechanism of antioxidant stress in atherosclerosisYuhan Sheng, Yizhuo Sun, Yang Tang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 4, 2023
Hydroxysafflor yellow A regulates lymphangiogenesis and inflammation via the inhibition of PI3K on regulating AKT/mTOR and NF-κB pathway in macrophages to reduce atherosclerosis in ApoE-/- miceXiaoteng Feng, Min Du, Sijin Li, et al.
Theranostics|October 3, 2022
Safety and efficacy of peptide receptor radionuclide therapy with <sup>177</sup>Lu-DOTA-EB-TATE in patients with metastatic neuroendocrine tumorsYuanyuan Jiang, Qingxing Liu, Guochang Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 26, 2024
Synthesis, preclinical evaluation and pilot clinical translation of [<sup>68</sup>Ga]Ga-PMD22, a novel nanobody PET probe targeting CLDN18.2 of gastrointestinal cancerRongxi Wang, Zhidong Bai, Wentao Zhong, et al.
Theranostics|April 17, 2026
Phase I dose-escalation study of [¹⁷⁷Lu]Lu-LNC1011, a long-circulating dansyl-modified PSMA theranostics, in metastatic castration-resistant prostate cancerJiarou Wang, Rongxi Wang, Jialin Xiang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2025
Comparison of [<sup>68</sup>Ga]Ga-Fibroblast Activation Protein Inhibitor-04 and [<sup>18</sup>F]FDG PET Imaging for Solitary Fibrous Tumor and Preliminary Application of FAP-Targeted Radiopharmaceutical TherapyRongxi Wang, Jiarou Wang, Jialin Xiang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 26, 2023
A prospective head-to-head comparison of [<sup>68</sup>Ga]Ga-P16-093 and [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancerGuochang Wang, Linlin Li, Ming Zhu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 4, 2023
Head-to-head comparison of [<sup>68</sup>Ga]Ga-P16-093 and 2-[<sup>18</sup>F]FDG PET/CT in patients with clear cell renal cell carcinoma: a pilot studyGuochang Wang, Linlin Li, Jiarou Wang, et al.
Clinical Nuclear Medicine|November 28, 2023
68 Ga-FAPI-04 PET/CT in Assessment of Fibroblast Activation in Keloids : A Prospective Pilot StudyJiarou Wang, Nanze Yu, Guochang Wang, et al.
Pageof 4